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Background: 1-Adrenergic receptors (-ARs) are expressed in the distal part of the nephron where TRPV5-mediated
active Ca2 reabsorption takes place.
Results: The 1-AR agonist dobutamine, by inducing PKA-dependent phosphorylation, enhanced influx of Ca2 through
TRPV5.
Conclusion: 1-AR signaling potentially stimulates transcellular Ca2 transport in the kidney.
Significance: Dobutamine, generally used as a positive inotrope, probably also has a calciotropic effect.
Epinephrine andnorepinephrine are present in the pro-urine.
-Adrenergic receptor (-AR) blockers administered to coun-
teract sympathetic overstimulation in patients with congestive
heart failure have a negative inotropic effect, resulting in
reduced cardiac contractility. Positive inotropes, 1-AR ago-
nists, are used to improve cardiac functions. Active Ca2 reab-
sorption in the late distal convoluted and connecting tubules
(DCT2/CNT) is initiated by Ca2 influx through the transient
receptor potential vanilloid type 5 (TRPV5) Ca2 channel.
Although it was reported that -ARs are present in the DCT2/
CNT region, their role in active Ca2 reabsorption remains elu-
sive. Here we revealed that 1-AR, but not 2-AR, is localized
with TRPV5 in DCT2/CNT. Subsequently, treatment of
TRPV5-expressing mouse DCT2/CNT primary cell cultures
with the 1-AR agonist dobutamine showed enhanced apical-
to-basolateral transepithelial Ca2 transport. In human embry-
onic kidney (HEK293) cells, dobutaminewas shown to stimulate
cAMP production, signifying functional 1-AR expression.
Fura-2 experiments demonstrated increased activity of TRPV5
in response to dobutamine, which could be prevented by the
PKAinhibitorH89.Moreover,nonphosphorylableT709A-TRPV5
and phosphorylation-mimicking T709D-TRPV5 mutants were
unresponsive to dobutamine. Surface biotinylation showed that
dobutamine did not affect plasma membrane abundance of
TRPV5. In conclusion, activation of1-AR stimulates active Ca2
reabsorption in DCT2/CNT; an increase in TRPV5 activity via
PKAphosphorylation of residue Thr-709 possibly plays an impor-
tant role. These data explicate a calciotropic role in addition to the
inotropic property of1-AR.
Ca2 plays a pivotal role in bone skeletal development and
acts as a secondmessenger in excitatory cells; thusmaintenance
of Ca2 homeostasis is vital for the body (1). Ca2 balance is
tightly regulated by three primary organs: the gastrointestinal
tract, bone, and the kidney (1). Ca2 absorbed from the intes-
tine is stored mostly in bone (99%) whereas the rest is either
conjugated with other charged molecules or freely circulating
in blood (2). The latter portion of Ca2 is filtered in the glom-
erulus of the kidney and is reabsorbed to the circulation by the
proximal tubule (PT,3 65%), thick ascending limb of Henle’s
loop (TAL, 20%), and DCT2/CNT (14%) (3). Mechanisms of
Ca2 reabsorption in these three segments are of different ori-
gin: passive Ca2 reabsorption through the paracellular space
in the PT andTAL, dependent on the electrochemical gradient,
whereas active transcellular Ca2 reabsorption in the DCT2/
CNT is energetically driven by ATP hydrolysis (1). Ca2 trans-
port in the TAL and DCT2/CNT is subject to regulation by
several factors including G protein-coupled receptors (GPCRs)
(1). Agonists of two members of GPCRs, i.e. Ca2-sensing
receptor and parathyroid hormone (PTH) receptor type 1,
inhibit and stimulate Ca2 reabsorption in TAL and in DCT2/
CNT, respectively (4–6).
Active Ca2 reabsorption in theDCT2/CNT is a crucial fine-
tuning event determining final urinaryCa2 excretion and con-
sists of three consecutive steps: apical entry through the tran-
sient receptor potential vanilloid type 5 (TRPV5)Ca2 channel,
intracellular buffering and translocation to basolateral mem-
brane by calbindin-D28K and extrusion into the blood by the
Na/Ca2 exchanger 1 and plasma membrane Ca2 ATPase
type 1b (1, 7, 8). TRPV5-mediated Ca2 influx is the rate-lim-
iting step for the active renal Ca2 reabsorption as shown by
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hypercalciuria and osteopenia in TRPV5-deficient mice (3).
Among six members of the vanilloid TRP family, TRPV5 is the
most Ca2-selective channel possessing a constitutive inward
rectifying property at low intracellular Ca2 concentrations
and physiological membrane potentials (9–11). Therefore, the
amount of Ca2 influx through the channel depends on chan-
nel activity and plasma membrane abundance (3). TRPV5
activity and plasmamembrane abundance are regulated by var-
ious factors, including GPCRs. For example, activation of bra-
dykinin receptor type 2 and PTH receptor type 1 initiate phos-
phorylation of TRPV5 through PLC/DAG/PKC and adenylyl
cyclase/cAMP/PKA signaling cascades, respectively (6, 12).
Epinephrine (Epi) and norepinephrine (NE) have diverse
hormonal and neurotransmitter functions in the body. Epi and
NE were shown to be present in pro-urine filtered from blood
but were also found to be synthesized by renal glomeruli/tu-
bules and released from renal sympathetic nerves (13). Epi and
NE can act through several members of GPCR adrenergic
receptors:1-AR,2-AR, and three-ARs. In kidney,1-AR is
expressed in arterioles whereas 2-AR is located predomi-
nantly in proximal tubules (14). 1-AR and 2-AR are respon-
sible for stimulation of renal vasoconstriction and Na reab-
sorption, respectively (14). -ARs can be divided into three
subtypes: 1-AR, 2-AR, and 3-AR (15, 16). 1 and 2-ARs
are reportedly expressed in rat and mouse DCT, whereas
3-AR is not detectable in the kidney (17–20). The roles of 1-
and 2-ARs are well known, respectively, for myocardial con-
traction and vasodilation, whereas 3-AR is important for
lipolysis (18, 21). -AR blockers (-blockers) are frequently
administered to counteract sympathetic overstimulation in
patients with congestive heart failure (CHF), resulting in
reduced cardiac contractility (22). Positive inotropes, 1-AR
agonists, are used to improve cardiac functions (22). Upon
stimulation by Epi and NE, -ARs activate G by the exchange
of GDP for GTP, which can further enhance the activity of
adenylyl cyclase and phospholipase C (PLC), mediators of
cAMP/protein kinaseA (cAMP/PKA)- and diacyl glycerol/pro-
tein kinase C (DAG/PKC)-dependent phosphorylation, respec-
tively (20).
Even though Epi andNE are secreted in the pro-urine, to our
knowledge, no effects of these hormones through signaling via
-ARs on renal active Ca2 transport have been reported. We
hypothesized that -ARs regulate active Ca2 reabsorption in
DCT2/CNT. Thus, the present study aims to investigate (i)
colocalization of 1- and 2-AR with TRPV5 in DCT2/CNT;
(ii) the effect of -AR activation by a -AR agonist on active
Ca2 reabsorption; and (iii) the molecular mechanism of
TRPV5 activation by -AR.
EXPERIMENTAL PROCEDURES
Immunohistochemistry—Mouse kidney sections were incu-
bated for 16 h at 4 °C with rabbit polyclonal antibody against
1-AR (1:100) or 2-AR (1:300) (NB100-92439 and NBP1-
68227; Novus Biologicals). To visualize the receptors, an
enhancer step was performed using a biotinylated goat anti-
rabbit antibody. Biotin was then coupled to streptavidin-HRP
and visualized with Thyramid (TSA Fluorescein System,
NEL701A001KT; PerkinElmer Life Sciences). TRPV5 staining
was described previously (4). Negative controls, i.e. conjugated
antibodies solely, were devoid of any staining.
Isolation of DCT2/CNT Using COPAS Sorting and Primary
Cell Culture—Transgenic mice expressing EGFP under the
TRPV5 promoter were generated as described (23). Mice were
maintained on a SSNIFF rodent complete diet (SSNIFF) with
free access to water. The animal ethics board of Radboud Uni-
versity Nijmegen approved all of the experimental procedures.
The process of renal tubular sorting byCOPAS (Union Biomet-
rica) has been described (24). Approximately 4,000–10,000
tubules from one mouse were pelleted (0.8  g, 5 min, 4 °C)
prior to culture or mRNA isolation as described below. For
primary culture 2,000 fluorescent tubules, a mixture of tubules
from two mice, were resuspended into warmed cell culture
medium (Dulbecco’s modified Eagle’s medium (DMEM)/
Ham’s F12; Invitrogen) with supplements as described (24) and
seeded onto 0.33-cm2 polycarbonate Transwell inserts (Corn-
ing Costar) previously coated with rat tail collagen (16l/insert
of 0.75mg/ml collagen in 95% v/v ethanol with 0.25% v/v acetic
acid). Volumes used in the apical and basolateral compart-
ments were 100 and 600 l, respectively. Cells were cultured at
37 °C in 5% v/v CO2, 95% v/v atmospheric air, and the medium
was refreshed every day.
45Ca2 Transport Measurement—For radioactive 45Ca2
transport experiments, primary cells cultured on Transwell
inserts as described above were used. Cells were used 7–8 days
after seeding; the day prior to the experiment transepithelial
electrical resistance was measured using an epithelial volt-
ohmmeter (World Precision Instruments). Cells were pre-
treated by adding 5M indomethacin to the culturemedium for
30 min. Culture medium was removed, and cells were washed
once with physiological salt solution (140 mMNaCl, 2 mM KCl,
1mMK2HPO4, 1mMMgCl2, 1mMCaCl2, 5mMD-glucose, 5mM
L-alanine, 5M indomethacin, 10mMHEPES/Tris, pH7.4). The
apical compartment contained 100l, and the basolateral com-
partment contained 600 l. Physiological salt solution was
replaced with the same volumes of the prewarmed identical
solution with and without 10 M dobutamine hydrochloride
(sc-203031; Santa Cruz Biotechnology); the apical medium
contained 3 Ci/ml 45Ca2. Ten microliters of basolateral
medium was collected at time points 0, 15, 30, 60, 120, and 180
min and analyzed for radioactivity in a PerkinElmer Life Sci-
ences liquid scintillation counter. Unidirectional flux from the
apical side to the basolateral side (JA3B) was calculated as
described previously (25).
Semiquantitative Real-time PCR—To evaluate mRNA
expression, RNA was extracted from pellets of 1,000 tubules
isolated byCOPAS usingTRIzolReagent (Invitrogen) accord-
ing to the manufacturer’s protocol. The obtained RNA was
reverse-transcribed byMoloney murine leukemia virus reverse
transcriptase (Invitrogen). cDNA was used to determine
mRNA expression levels by real-time PCR of Adrb1 (1-AR)
and Adrb2 (2-AR). As controls Trpv5 and Slc12a1 (Na-K-Cl
cotransporter 2, NKCC2) were included. The housekeeping
gene Gapdh was used as an endogenous control. Primers tar-
geting the genes of interest were designed using Primer3 and
are listed in Table 1. Normal PCR using AmpliTaq Gold
(Invitrogen) was performed on HEK293 cDNA to check for
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1-AR and 2-AR expression (primers: ADRB1 forward,
CCCAGAAGCAGGTGAAGAAG and reverse, CCCAGC-
CAGTTGAAGAAGAC; ADRB2 forward, GGCAGCTCCA-
GAAGATTGAC and reverse, TGGAAGGCAATCCT-
GAAATC); products were visualized on a 1.5% (w/v) agarose
gel.
Cell Culture and Transfection—HEK293 cells were grown in
DMEM (Bio Whittaker) containing 10% v/v fetal calf serum
(PAA), 2mM L-glutamine, 10l/ml nonessential amino acids at
37 °C in a humidity-controlled incubator with 5% CO2. Cells
were transiently transfected with the appropriate plasmids
using polyethyleneimine (PolySciences) with a DNA:polyethyl-
eneimine ratio of 1:6 for biochemical or live cell imaging
experiments.
Cell Surface Biotinylation and Immunoblotting—HEK293
cells (9 104 cells/cm2) were plated and transfected with 5 g
of TRPV5-HA pCINeo/IRES-GFP or pCINeo/IRES-GFP in
10-cm dishes. At 24 h after transfection cells were reseeded on
poly-L-lysine-coated (Sigma) 6-well plates. At 48 h after trans-
fection, cells were incubated for 1 h with 10 M dobutamine or
vehicle. Cells were homogenized in 1 ml of lysis buffer as
described previously (6) using the NHS-LC-LC-biotin (Pierce).
Finally, biotinylated proteins were precipitated using Neutr-
Avidin beads (Pierce). TRPV5 expression was analyzed by immu-
noblotting for the precipitates (plasma membrane fraction) and
for the total cell lysates using the anti-HA antibody (6).
Intracellular Ca2 and cAMP Measurements Using Fura-
2/AM and Exchange Protein Directly Activated by cAMP
(EPAC)-Enhanced GFP (EGFP)-mCherry—For combined
[Ca2]i and cAMP measurements, HEK293 cells were seeded
onto coverslips (Ø 25 mm) and cotransfected with the cAMP
sensor EPAC-EGFP-mCherry (26), kindly provided by Dr. K.
Jalink) for cAMP measurements, and the appropriate TRPV5
pCINeo/IRES-EGFP construct from which the sequence
encoding EGFPwas deleted. After 24 h, cells were loadedwith 3
M Fura-2/AM (Molecular Probes) and 0.01% v/v Pluronic
F-129 (Molecular Probes) in DMEM at 37 °C for 20 min. After
loading, cells were washed with PBS and allowed to equilibrate
at 37 °C for another 10 min in HEPES/Tris buffer (in mM: 132.0
NaCl, 4.2 KCl, 1.4 CaCl2, 1.0 MgCl2, 5.5 D-glucose, and 10.0
HEPES/Tris, pH 7.4). Changes in [Ca2]i and cAMP were
simultaneously monitored, using a modified Fura-2 protocol
allowing simultaneous measurements of Ca2 and cAMP (10).
Briefly, the cAMP sensor EPAC-EGFP-mCherry was excited at
488 using a monochromator. Fluorescence emission light was
directed by a 525DRLP dichroic mirror (Omega Optical)
through a 535af26 emission filter (EGFP fluorescence) and a
565ALP emission filter (mCherry fluorescence) onto a Cool-
SNAP HQmonochrome CCD camera. The integration time of
the CCD camera was set at 200 ms with a sampling interval of
5 s. All measurements were performed at room temperature.
Quantitative image analysis was performed with Metamorph
6.0 (Molecular Devices). For each wavelength, the mean fluo-
rescence intensitywasmonitored in an intracellular region and,
for purpose of background correction, an extracellular region of
identical size. After background correction, the fluorescence
emission ratio of 340 nm and 380 nm excitation was calculated
to determine the [Ca2]i while the fluorescence emission ratio
of the red and green fluorescence of the cAMP sensor was used
to determine changes in cellular cAMP content.
Statistical Analysis—If not specified otherwise, the data are
expressed as mean  S.E. The significant differences between
the means of two groups were analyzed by an unpaired
Student’s t test using the measurements per cell/sample (n9)
of at least three independent experiments. The level of statisti-
cal significance is p  0.05. All data were analyzed using
GraphPad Prism.
RESULTS
1-AR and 2-AR Are Expressed in DCT2/CNT—To inves-
tigate the role of1-ARand2-ARon activeCa2 reabsorption
in DCT2/CNT, immunohistochemical staining was performed
on frozen mouse kidney sections. Stainings showed colocaliza-
tion of 1-AR with TRPV5 in DCT2/CNT segments, but not
2-AR (Fig. 1, a and c). 1-AR and 2-AR antibody specificity
was evaluated by negative controls of secondary antibody only
(Fig. 1b, neg ctrl panel) and staining of liver tissue (Fig. 1b, liver
panel) reported to be negative for both 1-AR and 2-AR (27,
28).mRNAexpression of1-AR (Adrb1) and2-AR (Adrb2) in
DCT2/CNT cells isolated from pTRPV5-EGFP mice using the
COPAS Biosorter, was determined by real-time PCR. Results
showed that both 1-AR and 2-AR are enriched in DCT2/
CNT compared with total kidney cortex material, although the
expression level of1-AR is considerably higher (Fig. 2a), espe-
cially compared with the negative control NKCC2 (Slc12a1)
normally expressed in TAL. TRPV5 expression was used as a
positive control. Altogether, these results indicated that 1-AR
is expressed at the DCT2/CNT part of the nephron together
with TRPV5. At the cellular level, only part of the 1-AR signal
did colocalizewithTRPV5, suggesting expression in both apical
and basolateral areas (Fig. 1c).
Dobutamine Stimulates Transcellular Ca2 Transport in
MouseDCT2/CNT—Toexamine the role of1-AR stimulation
on Ca2 reabsorption in the distal part of the nephron, primary
DCT2/CNT tubules were cultured on Transwell inserts for 7/8
days allowing the formation of tight monolayers (transepithe-
TABLE 1
Musmusculus oligonuceotide sequences used in real-Time PCR
Adrb1, 1-adrenergic receptor gene; Adrb2, 2-adrenergic receptor gene; Trpv5, transient receptor potential vanilloid type 5 gene; Slc12a1, Na-K-Cl cotransporter 2 gene
(NKCC2); Gapdh, glyceraldehyde-3-phosphate dehydrogenase gene.
Gene Forward primer Reverse primer
Adrb1 GATCTGGTCATGGGATTGCT AAGTCCAGAGCTCGCAGAAG
Adrb2 CCTTAACTGGTTGGGCTACG GCTCTTGAAAGGCAATCCTG
Trpv5 CTGGAGCTTGTGGTTTCCTC TCCACTTCAGGCTCACCAG
Slc12a1 GGCTTGATCTTTGCTTTTGC CCATCATTGAATCGCTCTCC
Gapdh TAACATCAAATGGGGTGAGG GGTTCACACCCATCACAAAC
Activation of the1-AR Stimulates TRPV5 Activity
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FIGURE 2. Effect of 1-AR agonist (10 M dobutamine) on transepithelial Ca2 transport in mouse DCT2/CNT primary cultured monolayers. a,
mRNA enrichment of 1-AR (Adrb1) and 2-AR (Adrb2) in isolated mouse DCT2/CNT cells compared with total kidney cortex. TRPV5 (Trpv5) was used as
positive control, NKCC2 (Slc12a1) as negative control (n 6). b, Ca2 transport under control (open circles) and dobutamine (closed circles) conditions,
respectively. t15, t30, t60, t120, and t180 indicate time points of sample collections after 15-, 30-, 60-, 120-, and 180-min incubation. *, p  0.05 compared
with control at the same time point (n  7–8).
FIGURE 1.1-ARand2-ARexpression inmouse kidney. a, localization of1-AR,2-AR, and TRPV5 is depicted by immunohistochemistry onmouse kidney
tissue. b, negative controls of secondary antibody only and stainings of liver tissue are shown. c, higher magnification immunohistochemistry pictures of the
localization of 1-AR, 2-AR, and TRPV5 are shown.
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lial electrical resistance of 603  80 cm2 1 day prior to the
experiment). Transepithelial transport of Ca2 from the apical
to basolateral compartment wasmeasured by apical addition of
45Ca2 in the presence or absence of 10 M dobutamine, a
specific 1-AR agonist, in both the apical and basolateral solu-
tion. Transport of Ca2 was significantly increased by 10 M
dobutamine (19 2 and 30 4 nmolh1cm2 for control and
dobutamine, respectively, p 0.05) after 60 min (Fig. 2b).
1-ARAgonist Stimulates cAMPProduction inHEK293Cells—
To study the role of the Ca2 channel TRPV5 in 1-AR-medi-
ated activation of transcellular Ca2 transport, we examined
the effect of dobutamine in HEK293 cells, which were reported
to express1-AR (29). First, the expression of1- and2-AR in
HEK293 cells was confirmed (Fig. 3). Identity of the observed
bands was verified by sequencing of the respective PCR prod-
ucts. Because 1-AR activation leads to cAMP production (18)
the 1-AR-mediated TRPV5 Ca2 influx in HEK293 cells
transfected with the cAMP sensor EPAC and TRPV5 was stud-
ied as described under “Experimental Procedures.” The EPAC
and Fura-2 ratios weremeasured before (t 0min, t0) and after
(t 3 min, t3) dobutamine treatment (10 M) (Fig. 4, a and d).
The EPAC ratio plotted at t0 and t3 indicated a significant
increase in cAMP levels after a 2-min incubation with dobu-
tamine as measured by a 5.1  0.1% increase in the EGFP:
mcherry ratio due to loss of the FRET signal upon binding of
cAMP (Fig. 4b). Fura-2 ratios were increased by 19.5  0.3%
upon stimulation by dobutamine (Fig. 4e). The dobutamine-
induced increase in EPAC and Fura-2 ratio was dose-depen-
dent (Fig. 4, c and f), implying that 1-AR signaling can func-
tionally stimulate TRPV5 activity in HEK293 cells.
Dobutamine Does Not Change TRPV5 Protein Abundance at
the Plasma Membrane—Ca2 influx through TRPV5 is regu-
lated by plasmamembrane abundance and activity of the chan-
nel (3). The effect of dobutamine on TRPV5 plasmamembrane
expressionwas assessed inHEK293 cells transiently transfected
with TRPV5 using cell surface biotinylation. A 60-min incuba-
tion with 10 M dobutamine did not affect plasma membrane
abundance of TRPV5 (Fig. 5, a and b). Total expression of
TRPV5 in the dobutamine-treated cells did not differ from con-
trol as well (Fig. 5a).
Dobutamine Stimulates TRPV5-mediated Ca2 Uptake in
HEK293 Cells via PKA Phosphorylation of Thr-709 Residue—
TRPV5 channel activity is known to be stimulated by cAMP/
PKA-mediated pathways (6). HEK293 cells were transfected
with TRPV5 and loaded with the Fura-2 Ca2 sensor to mea-
sure Ca2 uptake. After a 1-min incubation with dobutamine,
Ca2 uptake reached maximal activation, 	2 times elevated
compared with basal uptake levels (Fig. 6a). Interestingly, these
stimulatory effects were prevented when the cells were prein-
cubated (30 min) with the PKA inhibitor, H89 (Fig. 6, a and b),
indicating that 1-AR activation is mediated by PKA phosphor-
ylation of the TRPV5 channel. Previously, a threonine residue
709 on the C terminus of TRPV5 was identified as the sole
TRPV5 PKA phosphorylation site (10). To study the effects of
dobutamine on phosphorylation of TRPV5 at this residue,WT-
TRPV5, nonphosphorylated mutant T709A-TRPV5, and the
T709D-TRPV5mutant mimicking phosphorylation at this res-
idue were used. The stimulatory effect of dobutamine was
absent in the nonphosphorylable T709A-TRPV5 mutant and
the phosphorylation-mimicking T709D-TRPV5 mutant, the
latter already showing activation, indicating that the Thr-709
residue is crucial for 1-AR-mediated PKA phosphorylation
(Fig. 6, c and d).
DISCUSSION
The present study indicates that activation of 1-AR stimu-
lates TRPV5-mediated Ca2 transepithelial transport via PKA
phosphorylation of the Ca2 channel. Our conclusion relies on
the following findings: (i) 1-AR colocalizes with TRPV5 in
mouse DCT2/CNT; (ii) the 1-AR agonist dobutamine stimu-
lates cAMP production and TRPV5-mediated Ca2 uptake in
HEK293 cells; (iii) dobutamine increases the TRPV5 channel
activity which can be prevented by the PKA inhibitor H89 and
mutation of the channel at the Thr-709 residue; (iv) dobu-
tamine stimulates the apical-to-basolateral transepithelial
Ca2 flux in the mouse primary DCT2/CNT culture.
To our knowledge, the expression profile and the conse-
quences of activation of -ARs in mouse DCT2/CNT have not
been characterized. Boivin and colleagues elaborately investi-
gated 1- and 2-ARs in rat kidney by immunohistochemistry
(17). In their study, 2-AR is faintly present in DCT and unde-
tectable in CNT (17), whereas in our study 2-AR did not colo-
calize with TRPV5 in the mice DCT2/CNT. For 1-AR, Boivin
et al. showed colocalization with calbindin-D28K on the apical
membrane (17) in line with our finding that 1-AR colocalizes
with TRPV5, although we did not observe a clear apical
localization.
Gesek and White demonstrated that the immortalized
mouseDCTcell line expresses both1- and2-ARs (30). In the
present study, both receptors were detected by PCR inmaterial
from DCT2/CNT as isolated by the COPAS biosorter. Consid-
ering the lower amounts of 2-AR detected in highly enriched
DCT2/CNT material, combined with the absence of 2-AR in
immunohistological stainings inDCT2/CNT, we conclude that
2-AR seems not present in the DCT2/CNT. Gesek and Fried-
man showed that isoproterenol stimulated both cAMPproduc-
tion and Na uptake, but not Ca2 influx into the cells (31).
However, they selected thiazide-sensitive DCT1 cells, which
contain no TRPV5, resulting in very low Ca2 transport rates
(20, 24, 31). In contrast, in the present study, DCT2/CNT
tubuleswere selectively sorted fromTRPV5-expressing cells. In
the polarized mouse primary DCT2/CNT culture we demon-
strated that dobutamine stimulates apical-to-basolateral tran-
sepithelial Ca2 transport. Due to generally lower expression
levels of 1-AR, in primary cultures compared with the in vivo
FIGURE 3. Expression of 1- and 2-AR in HEK293 cells.  and  signify
PCR products of reverse-transcribed and non-reverse-transcribed mRNA,
respectively. Product sizes were 346 bp for 1-AR and 328 bp for 2-AR.
Activation of the1-AR Stimulates TRPV5 Activity
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situation, relatively high concentrations of dobutamine were
applied (10 M) to stimulate transepithelial Ca2 transport
maximally.
HEK293 cells are generally used as amodel for studyingmolec-
ular mechanism of TRPV5-mediated Ca2 uptake because they
lack endogenous expression of this Ca2 channel (32), allowing
transfection of exogenous wild-type (WT) or residue-specific
TRPV5 mutants. In addition, due to overexpression of TRPV5
faster and stronger effects are to be expected compared with pri-
mary cultures. Moreover, the cells were reported to express
1-AR, which could be stimulated by a nonspecific -AR agonist
isoproterenol, showing enhanced cAMP synthesis (29). Here, we
show that the intracellular level of cAMP is increasedwithinmin-
utesafteradditionofdobutamine, indicating that1-ARwas func-
tionally expressed in HEK293 cells and that the cells are suitable
for studying 1-AR-initiated intracellular signaling. Accordingly,
dobutamine was demonstrated to stimulate Ca2 uptake in
TRPV5-expressing HEK293 cells with maximal activation at 2
min.This rapidactionof theagonist is likelynongenomicas exem-
plified by the hormonal action of PTH on TRPV5 activity that
exerted similar maximal stimulation within 2 min. It is reported
that TRPV5 activation is stimulated by the cAMP-dependent
PTH1R signaling pathway leading to PKA-mediated phosphory-
lation of TRPV5 on the C terminus of the channel (6). Moreover,
Topala and colleagues showed that the activation of the Ca2-
sensing receptor induces TRPV5-mediated Ca2 peak current in
1 s (4). They elaborated that the Ca2-sensing receptor agonist
neomycinmediated PKCphosphorylation of the residues Ser-299
and Ser-654. Interestingly, Gkika and co-workers demonstrated
that long term(1-h) stimulationof bradykinin receptor type2with
tissue kallikrein resulted in increased plasmamembrane accumu-
lation of TRPV5 (12). In the present study, however, 1-h dobu-
tamine incubation did not affect plasmamembrane abundance or
total expression of TRPV5. Altogether, activation of 1-AR
enhanced TRPV5 activity via cAMP-dependent PKA phosphory-
lationof theTRPV5channel at residueThr-709 in the intracellular
C terminus.
FIGURE 4. Effect of 1-AR agonist dobutamine on cAMP production and Ca2 uptake in HEK293 cells transiently transfected with TRPV5 and EPAC
sensor. a, averaged EPAC trace upon the addition of 10M dobutamine (Dob) (n 60 cells). b, EPAC ratios before (t0) and after (t3) dobutamine stimulation. *,
p 0.05 compared with t0 (n 60 cells). c, dose-response curve of the effect of dobutamine treatment on cAMP production as measured by EPAC ratios (t3
compared with t0) (n 28–76 cells/condition). d, averaged Fura-2 trace upon the addition of 10 M dobutamine (n 59 cells) e, Fura-2 ratios demonstrated
before (t0) and after (t3) dobutamine stimulation. *, p 0.05 compared with t0 (n 59 cells). f, dose-response curve of the effect of dobutamine treatment on
Ca2 uptake as measured by Fura-2 ratios (t3 compared with t0) (29–70 cells/condition).
FIGURE 5. Effect of 1-AR agonist on plasma membrane abundance of
TRPV5. a, TRPV5-transfected HEK293 cells were treated for 60 min with or
without 10 M dobutamine. NHS-LC-LC-biotin was added to medium for 30
min before the cells were lysed, and the biotinylated (plasma membrane)
fraction was pulled down using neutravidin-agarose beads. Representative
immunoblot is shown for TRPV5 analyzed for plasma membrane and total
expression. CTRL, control; Dob, dobutamine-treated. b, calculated immuno-
blot densities (n 9).
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Apart from the classic cAMP-dependent signaling mecha-
nism of -ARs, 1-AR has been reported to be PLC-dependent
(20). In the study by Kang and colleagues, a nonspecific -AR
agonist isoproterenol stimulated Mg2 uptake in isolated
mouse DCT1 cell culture (20). Isoproterenol is known to bind
preferentially to 1-AR and to a lesser extent to 2-AR. In the
latter study, both PKA and PLC inhibitors inhibited the stimu-
latory effects of isoproterenol. Phorbol 12-myristate-13-ace-
tate, a DAG analog, had no effect on Mg2 reabsorption, but
potentiated effects of isoproterenol (20). There is no report of
dobutamine action on signaling mechanisms other than the
cAMP-dependent pathway, and the PKA inhibitor H89 com-
pletely blocked the dobutamine action. Thus, the1-AR signal-
ing pathway in the present study seems to bemediated solely by
the cAMP/PKA.
The present study indicates a novel calciotropic role of dobu-
tamine in renal DCT2/CNT in addition to the positive ino-
tropic effect in cardiacmyocytes. In addition,-blockerswidely
used in treatment of CHF might have adverse effects on main-
taining body Ca2 homeostasis. CHF initiates when the heart
fails to supply sufficient blood tomatch the body demanddue to
reduced cardiac contractility (21, 33). Heart rate is accelerated
(34), leading to a decreased effective circulating volume, which
in turn triggers the renin-angiotensin-aldosterone system in
the kidney (35). As a result of CHF, patients develop secondary
aldosteronism leading to increased fecal and urinary Ca2
excretion (36). In addition, patients are generally treated with
loop diuretics and often suffer from vitamin D deficiency (36,
37). Moreover, hypercalciuria and osteopenia have been impli-
cated in patients with advanced CHF awaiting cardiac trans-
plantation (36, 38). Hence, potential calciotropic effects of
-blockers might further increase chances of developing
hypocalcemia in these patients. In addition,-blockers are used
to resolve hypercalcemia among other symptoms in hyperthy-
roidism (39, 40). The mechanism of action of -blockers in
hyperthyroidism is unclear, but principally appears to antago-
nize overstimulated -AR-mediated signaling. Interestingly,
the Ca2-lowering effect of propranolol (nonselective
-blocker) was proposed to be caused by a direct effect on bone
or renal Ca2 handling (40).
In conclusion, the present study demonstrates that dobu-
tamine, a 1-AR agonist, stimulates TRPV5 activity via a PKA-
dependent pathway. PKA activation results in phosphorylation
of the Thr-709 residue and consequently enhances TRPV5
activity. Epi andNE, by activating TRPV5 activity, could poten-
tially be involved in normal physiological renal Ca2 handling
in the DCT2/CNT. Therefore, -adrenergic receptor agonists
and blockers, increasingly administered to patients, potentially
exert adverse calciotropic effects.
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